Want to join the conversation?
$VRSK's revenue for its Risk Assessment segment for 2015 increased by 5.8% from the previous year. The overall increase within this segment primarily resulted from a rise in prices derived from continued enhancements to the content of its industry-standard insurance programs' solutions as well as selling expanded solutions to existing customers.
Keep your eyes on $FLXN. This one could ascend rapidly. Great time to buy your favourite bio stocks. Make more $$$
$CRM on the pop today.. big bubble.
Slumping and down the drain... $HDSN. Flush out your holdings !
$KITE I am loving this one... really flying like a kite today :-)